Sleep and circadian rhythm disruption in schizophrenia K Wulff, DJ Dijk, B Middleton, RG Foster, EM Joyce The British Journal of Psychiatry 200 (4), 308-316, 2012 | 543 | 2012 |
The effect of morphine applied locally to mesencephalic dopamine cell bodies on spontaneous motor activity in the rat EM Joyce, SD Iversen Neuroscience letters 14 (2-3), 207-212, 1979 | 448 | 1979 |
Comorbid substance use and age at onset of schizophrenia TRE Barnes, SH Mutsatsa, SB Hutton, HC Watt, EM Joyce The British Journal of Psychiatry 188 (3), 237-242, 2006 | 417 | 2006 |
Executive function in first-episode schizophrenia SB Hutton, BK Puri, LJ Duncan, TW Robbins, TRE Barnes, EM Joyce Psychological medicine 28 (2), 463-473, 1998 | 417 | 1998 |
Do patients with schizophrenia exhibit aberrant salience? JP Roiser, KE Stephan, HEM Den Ouden, TRE Barnes, KJ Friston, ... Psychological medicine 39 (2), 199-209, 2009 | 332 | 2009 |
West London first-episode study of schizophrenia: clinical correlates of duration of untreated psychosis TRE Barnes, SB Hutton, MJ Chapman, S Mutsatsa, BK Puri, EM Joyce The British Journal of Psychiatry 177 (3), 207-211, 2000 | 321 | 2000 |
The size, burden and cost of disorders of the brain in the UK NA Fineberg, PM Haddad, L Carpenter, B Gannon, R Sharpe, AH Young, ... Journal of Psychopharmacology 27 (9), 761-770, 2013 | 316 | 2013 |
Frontal lobe function in Korsakoff and non-Korsakoff alcoholics: planning and spatial working memory EM Joyce, TW Robbins Neuropsychologia 29 (8), 709-723, 1991 | 273 | 1991 |
Cognitive heterogeneity in schizophrenia EM Joyce, JP Roiser Current opinion in psychiatry 20 (3), 268-272, 2007 | 261 | 2007 |
Verbal fluency in schizophrenia: relationship with executive function, semantic memory and clinical alogia EM Joyce, SL Collinson, P Crichton Psychological medicine 26 (1), 39-49, 1996 | 259 | 1996 |
Neural and behavioral correlates of aberrant salience in individuals at risk for psychosis JP Roiser, OD Howes, CA Chaddock, EM Joyce, P McGuire Schizophrenia bulletin 39 (6), 1328-1336, 2013 | 254 | 2013 |
A unified connectomic target for deep brain stimulation in obsessive-compulsive disorder N Li, JC Baldermann, A Kibleur, S Treu, H Akram, GJB Elias, A Boutet, ... Nature communications 11 (1), 3364, 2020 | 253 | 2020 |
Neuropsychological predictors of clinical outcome in opiate addiction F Passetti, L Clark, MA Mehta, E Joyce, M King Drug and alcohol dependence 94 (1-3), 82-91, 2008 | 253 | 2008 |
Randomised feasibility study of physiotherapy for patients with functional motor symptoms G Nielsen, M Buszewicz, F Stevenson, R Hunter, K Holt, M Dudziec, ... Journal of Neurology, Neurosurgery & Psychiatry 88 (6), 484-490, 2017 | 252 | 2017 |
Evidence-based guidelines for the pharmacological treatment of schizophrenia: updated recommendations from the British Association for Psychopharmacology TRE Barnes, R Drake, C Paton, SJ Cooper, B Deakin, IN Ferrier, ... Journal of Psychopharmacology 34 (1), 3-78, 2020 | 239 | 2020 |
Discrimination learning, reversal, and set-shifting in first-episode schizophrenia: stability over six years and specific associations with medication type and disorganization … VC Leeson, TW Robbins, E Matheson, SB Hutton, MA Ron, TRE Barnes, ... Biological psychiatry 66 (6), 586-593, 2009 | 239 | 2009 |
Efficacy and safety of deep brain stimulation in Tourette syndrome: the international Tourette syndrome deep brain stimulation public database and registry D Martinez-Ramirez, J Jimenez-Shahed, JF Leckman, M Porta, D Servello, ... JAMA neurology 75 (3), 353-359, 2018 | 236 | 2018 |
Executive dysfunction in first-episode schizophrenia and relationship to duration of untreated psychosis: the West London Study E Joyce, SAM Hutton, S Mutsatsa, H Gibbins, E Webb, S Paul, T Robbins, ... The British Journal of Psychiatry 181 (S43), s38-s44, 2002 | 233 | 2002 |
The Gilles de la Tourette syndrome–Quality of Life Scale (GTS-QOL) development and validation AE Cavanna, A Schrag, D Morley, M Orth, MM Robertson, E Joyce, ... Neurology 71 (18), 1410-1416, 2008 | 226 | 2008 |
Assessing cognitive function in clinical trials of schizophrenia JH Barnett, TW Robbins, VC Leeson, BJ Sahakian, EM Joyce, ... Neuroscience & Biobehavioral Reviews 34 (8), 1161-1177, 2010 | 211 | 2010 |